Literature DB >> 1631795

Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.

Z Bin1, L Kun.   

Abstract

Glaucocalyxin A is a new diterpenoid isolated from the ethereal extract of the leaves of Rabdosia japonica (Burm f) Hara var glaucocalyx (Maxim) Hara (Labiatae) collected in the northeastern China. When it was incubated with washed rabbit platelets, glaucocalyxin A inhibited ADP- or arachidonic acid-induced platelet aggregation with IC50 values of 4.4 mumol/l, 14.1 mumol/l respectively. Glaucocalyxin A also inhibited PAF-induced aggregation of rabbit platelets which were refractory to ADP and arachidonic acid with an IC50 value of 13.7 mumol/l. Analysis of [3H]-PAF binding showed that glaucocalyxin A prevented [3H]-PAF binding to intact washed rabbit platelets with an IC50 value of 8.16 mumol/l, which was consistent with its inhibition of PAF-induced platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1631795

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Leukamenin F suppresses liver fibrogenesis by inhibiting both hepatic stellate cell proliferation and extracellular matrix production.

Authors:  Qiong Liu; Xu Wang; Yu Zhang; Chen-jing Li; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

2.  Anti-hepatoma activity of a novel compound glaucocalyxin H in vivo and in vitro.

Authors:  Guangfan Hai; Chong Zhang; Yanlong Jia; Suping Bai; Jinfen Han; Lanqing Guo; Taizhen Cui; Bingxuan Niu; Feng Huang; Yu Song
Journal:  AAPS PharmSciTech       Date:  2014-11-06       Impact factor: 3.246

3.  Preparation and antitumor effects of glaucocalyxin A-γ-cyclodextrin clathrate.

Authors:  Chong Zhang; Yan Qu; Yan-Long Jia; Xiao-Jun Shang; Su-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway.

Authors:  Wei Li; Xiaorong Tang; Wenxiu Yi; Qiang Li; Lijie Ren; Xiaohui Liu; Chunjun Chu; Yukio Ozaki; Jian Zhang; Li Zhu
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.